Icon

PEDMARK (NDA212937)- (12.5GM/100ML (125MG/ML))

SODIUM THIOSULFATE FENNEC PHARMS INC
12.5GM/100ML (125MG/ML)
Yes Yes
2039-Jul-01 Expired
None 2025-Sep-20
None No
PEDMARK is indicated to reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
0 0 0
Total Other Developers None
Drugs with Suitability No
12.5GM/100ML (125MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.